Medical Director Spotlight
In the spring of 2018, Dr. Emerson Perin was appointed by the THI Board of Trustees to serve as the new Medical Director and is already making tremendous progress toward positioning THI for unparalleled growth.
“I have spent my entire practicing career supporting THI, learning from and practicing with pioneers in the cardiovascular discipline. I am honored to take on this new role and work with my peers to ensure that the THI spirit and drive for discovery continue.”
— Emerson Perin, MD, PhD
In the spring of 2018, Dr. Emerson Perin was appointed by the THI Board of Trustees to serve as the new Medical Director and is already making tremendous progress toward positioning THI for unparalleled growth.
Dr. Perin has built an internationally recognized preclinical and clinical stem cell research program and has contributed to important discoveries and advancements in interventional cardiology.
As Medical Director, Dr. Perin will now govern THI’s professional staff of researchers and provide counsel and guidance on all research and education initiatives to ensure continuity and alignment with THI’s vision.
Dr. Perin joined the THI family 30 years ago as a clinical fellow in training and graduated as the Outstanding Cardiology Fellow of his class. Since then, Dr. Perin has provided interventional cardiology services in his private practice in the Texas Medical Center and contributed to THI’s mission through both research and postgraduate teaching.
His passion for discovering new therapeutic solutions for patients suffering from heart disease has been the primary focus of his research since 1998. His work has earned him multiple honors, including being named a McNair Scholar in 2013.
Dr. Perin has led clinical trials focused on improving the treatment of heart failure, heart attacks, refractory angina, and peripheral arterial disease. He has also served as the Principal Investigator in the National Heart, Lung, and Blood Institute (NHLBI) Cardiovascular Cell Therapy Research Network, which is a national research consortium funded by the NHLBI.
In 2018, Dr. Perin founded the Center for Clinical Research (CCR) to support all areas of clinical cardiovascular research at THI. The CCR supports all areas of cardiovascular clinical research, from protocol development to trial facilitation, post-trial assessment, and reporting.
